aTyr Pharma to Participate in Upcoming Investor Conferences

Rhea-AI Summary

aTyr Pharma (Nasdaq: ATYR) will participate in two investor conferences in New York in May and June 2026. Events include the RBC Capital Markets Global Healthcare Conference on May 20 with 1x1 meetings and the Jefferies Global Healthcare Conference on June 4 featuring a fireside chat.

A webcast and 90-day replay of the Jefferies presentation will be available on aTyr’s investor relations website.

News Market Reaction – ATYR

+41.42% 7.6x vol

58 alerts

+41.42% Session close to close

+3.6% Peak Tracked

-29.5% Trough Tracked

$56.61M Market Cap

7.6x Rel. Volume

In the May 14 session, ATYR gained 41.42%, reflecting a significant positive market reaction. Argus tracked a peak move of +3.6% during that session. Argus tracked a trough of -29.5% from its starting point during tracking. Our momentum scanner triggered 58 alerts that day, indicating high trading interest and price volatility. Trading volume was exceptionally heavy at 7.6x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in May and June 2026.

Details of the conferences appear below:

Conference: RBC Capital Markets Global Healthcare Conference
Date: Wednesday, May 20, 2026
Location: New York, NY
Format: 1x1 Investor Meetings

Conference: Jefferies Global Healthcare Conference
Date: Thursday, June 4, 2026
Time: 3:45pm ET
Location: New York, NY
Format: Fireside Chat
Speaker: Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer

In addition to the presentation, company management will be available to participate in one-on-one meetings with investors who are registered attendees of the Jefferies conference. A webcast of the Jefferies event will be available on the Investor’s section of the company’s website at www.atyrpharma.com. Following the event, a replay of the presentation will be available on the aTyr website for at least 90 days. For more information, contact investorrelations@atyrpharma.com.

About aTyr

aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases are ancient, essential proteins that have evolved novel domains that regulate diverse pathways extracellularly in humans. aTyr’s discovery platform is focused on unlocking hidden therapeutic intervention points by uncovering signaling pathways driven by its proprietary library of domains derived from all 20 tRNA synthetases. aTyr’s lead therapeutic candidate is efzofitimod, a novel biologic immunomodulator in clinical development for the treatment of interstitial lung disease, a group of immune-mediated disorders that can cause inflammation and progressive fibrosis, or scarring, of the lungs. For more information, please visit www.atyrpharma.com.

Contact:
Ashlee Dunston
Sr. Director, Investor Relations and Public Affairs
adunston@atyrpharma.com

FAQ

When will aTyr Pharma (ATYR) present at the Jefferies Global Healthcare Conference 2026?

aTyr Pharma will present at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, at 3:45 p.m. ET. According to aTyr, the event will feature a fireside chat with CEO Dr. Sanjay S. Shukla in New York.

What is aTyr Pharma’s schedule at the RBC Capital Markets Global Healthcare Conference 2026?

aTyr Pharma is scheduled to attend the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026. According to aTyr, the company will participate in 1x1 investor meetings in New York, offering institutional investors direct access to company management.

How can investors watch aTyr Pharma’s (ATYR) Jefferies 2026 conference presentation?

Investors can watch aTyr Pharma’s Jefferies presentation via webcast on the company’s investor relations website. According to aTyr, a replay of the fireside chat will remain accessible online for at least 90 days following the June 4, 2026 event.

Will aTyr Pharma management hold one-on-one investor meetings at the Jefferies 2026 conference?

Yes, aTyr Pharma management will be available for one-on-one meetings with registered Jefferies conference attendees. According to aTyr, these meetings occur in addition to the scheduled fireside chat and allow deeper discussion of its clinical pipeline and strategy.

Who will represent aTyr Pharma (ATYR) at the Jefferies Global Healthcare Conference 2026?

aTyr Pharma will be represented by Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer. According to aTyr, Dr. Shukla will participate in a fireside chat and engage with investors during one-on-one meetings at the New York event.

What does aTyr Pharma do and what is its lead clinical candidate?

aTyr Pharma is a clinical-stage biotech developing therapies from its tRNA synthetase platform targeting fibrosis and inflammation. According to aTyr, its lead candidate, efzofitimod, is a novel biologic immunomodulator in clinical development for interstitial lung disease.